Debora Collotta and Massimo Collino (2016) “NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation”, Diabetes Research, 3(1), pp. e1-e3. Available at: https://openventio.us/index.php/DR/article/view/1635 (Accessed: 28 July 2026).